Sutro Biopharma Inc. filed SEC Form 8|K
All SEC Filings - Sutro Biopharma, Inc.
Form 10-Q: Quarterly report pursuant to Section 13 or 15(d), 103. 11/13/24, 8-K, Form 8-K: Current report filing, 9. 11/13/24, SC 13G/A, Form SC 13G/A: Schedule ...
April 2, 2024 - 8-K: Current report filing | Sutro Biopharma, Inc. (STRO)
April 2, 2024 > Form 8-K > Sutro Biopharma, Inc. Document ... Company files from time to time with the Securities and Exchange Commission.
August 12, 2024 - 8-K: Current report filing - Sutro Biopharma, Inc.
UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 8-K. CURRENT REPORT. Pursuant to Section 13 or 15(d) of the ...
SUTRO BIOPHARMA, INC. - EDGAR Entity Landing Page
[+] 8-K (current reports). August 13, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**.
All SEC Filings - Sutro Biopharma, Inc.
Form 4: Statement of changes in beneficial ownership of securities, 1. 06/10/24, 8-K, Form 8-K: Current report filing, 4. 06/10/24, 4, Form 4: Statement of ...
All SEC Filings - Sutro Biopharma, Inc.
8-K, Form 8-K: Current report filing, 4. 09/19/23, 4, Form 4: Statement of changes in beneficial ownership of securities, 1. 09/19/23, 3, Form 3: Initial ...
Sutro Biopharma Inc. filed SEC Form 8-K: Results of Operations and ...
Sutro Biopharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits. 11/13/24 4:30: ...
All SEC Filings - Sutro Biopharma, Inc.
SEC Filings ; 04/28/23, DEF 14A, Form DEF 14A: Definitive proxy statements ; 04/27/23, 8-K · Form 8-K: Current report filing ; 04/17/23, 4, Form 4: Statement of ...
All SEC Filings - Sutro Biopharma, Inc.
8-K, Form 8-K: Current report filing, 47. 02/09/24, 424B5, Form 424B5: Prospectus filed pursuant to Rule 424(b)(5), 49. 02/07/24, SC 13G/A, Form SC 13G/A: ...
All SEC Filings - Sutro Biopharma, Inc.
06/07/22, 8-K · Form 8-K: Current report filing ; 05/19/22, EFFECT, Form EFFECT: Notice of Effectiveness ; 05/18/22, POS EX, Form POS EX: Post-effective amendment ...
08/13/2024 - Sutro Biopharma, Inc.
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under ...
All SEC Filings :: Sutro Biopharma, Inc. (STRO)
SEC Filings ; 01/08/24, 8-K · Form 8-K: Current report filing, 34 ; 12/04/23, 4, Form 4: Statement of changes in beneficial ownership of securities, 1.
EDGAR Filing Documents for 0001564590-21-055917 - SEC.gov
Form 8-K - Current report: SEC Accession No. 0001564590-21-055917 ... SUTRO BIOPHARMA, INC. (Filer) CIK : 0001382101 (see all company ...
Form 8-K SUTRO BIOPHARMA, INC. For: Jun 06 - StreetInsider
Delaware. 001-38662. 47-0926186 ; (State or other jurisdiction. of Incorporation). (Commission. File Number). (IRS Employer. Identification No.) ...
All SEC Filings - Sutro Biopharma, Inc.
Form 3: Initial statement of beneficial ownership of securities, 2. 11/08/18, 8-K, Form 8-K: Current report filing, 3. 10/09/18, SC 13D, Form SC 13D: Schedule ...
All SEC Filings - Sutro Biopharma, Inc.
SEC Filings ; 03/01/22, POS AM, Form POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing ; 02/28/22, 8-K ...
All SEC Filings :: Sutro Biopharma, Inc. (STRO)
SEC Filings ; 03/03/20, 8-K · Form 8-K: Current report filing ; 02/27/20, 4, Form 4: Statement of changes in beneficial ownership of securities ; 02/14/20, SC 13G/A ...
Sutro Biopharma Inc (STRO) 8-K Event for Officers - Aug 2024
Sutro Biopharma, Inc. (STRO) SEC Filing 8-K Material Event for the period ending Thursday, August 8, 2024.
February 9, 2024 - EX-5.1 - 8-K: Current report filing
We deliver this opinion with respect to certain matters in connection with the sale by Sutro Biopharma, Inc., a Delaware corporation (the “ ...
SUTRO BIOPHARMA, INC. (Exact name of registrant ... Check the appropriate box below if the Form 8-K filing ... Further, on November 13, 2023, the Company filed a ...